Concurrent mixed methods design diagram. by Esario IV Daguman (21474116)

Subjects:

Outcomes and data gathering timeline. by Esario IV Daguman (21474116)

Subjects:

The guiding map. by Esario IV Daguman (21474116)

Subjects:

Summary of five key points guiding the Safe Steps evaluation and implementation. by Esario IV Daguman (21474116)

Subjects:

In vivo combination activity of AMG 510 and pemigatinib in epithelial-like or mesenchymal-like phenotype lung cancer PDX models. by Angela Abdollahi (15166230)

RT-qPCR Primer. by Dequan Wang (6007007)

Subjects:

miR-1247-3p plasmid. by Dequan Wang (6007007)

Subjects:

Dual luciferase primer. by Dequan Wang (6007007)

Subjects:

shCCND1 plasmid. by Dequan Wang (6007007)

Subjects:

S1 Raw images - by Dequan Wang (6007007)

Subjects:

Introduction to the dataset. by Dequan Wang (6007007)

Subjects:

S1 Data - by Richard Junior Zapata Dongo (17912565)

Subjects:

269 miRNAs of the 8 DSERGs. by Wei He (131453)

Subjects:

Comprehensive list of all SRGs. by Wei He (131453)

Subjects:

A total of 700 DEGs. by Wei He (131453)

Subjects:

Carbon isotopes. by Sarah J. Noe (19846136)

Subjects:

Supplementary Material for: Allopurinol Use is Associated With Decreased Incidence of Hepatic Decompensation and Overall Mortality Among Individuals With Cirrhosis: a Propensity-ma... by figshare admin karger (2628495)

“…Background: Cirrhosis is associated with significant morbidity and mortality. Recent studies have highlighted the potential role of allopurinol in reducing the incidence of hepatic decompensation among individuals with cirrhosis. …”

CK8 knockdown and ROCK1 inhibitor abolished rTsSPc-reduced TJs expression in Caco-2 monolayers by IFA. by Wen Wen Zheng (17721404)

Subjects:

Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. by Richard Junior Zapata Dongo (17912565)

Subjects:

Loss of mammary fitness and virulence by <i>M</i>. <i>bovis</i> 0690::Tn mutant. by Aga E. Gelgie (17661720)

Subjects: